 | Ubenimex | IC50 | 4000.0 [1] |
 | Ubenimex | Ki | 320.0 [1] |
 | Captopril | IC50 | 70.0 [1], 3600.0 [2], 10000.0 [3], 14000.0 [4] |
 | Captopril | Ki | 3700.0 [1] |
 | Kelatorphan | IC50 | 5.0 [1], 50000.0 [2] |
 | Kelatorphan | Ki | 10.0 [1], 18.0 [2] |
 | N-[3-(4-Benzylphenoxy)propyl]-N-Methyl-beta-Alanine | IC50 | 2.5 [1], 6.0 [2], 49.0 [3] |
 | N-[3-(4-Benzylphenoxy)propyl]-N-Methyl-beta-Alanine | Ki | 3.0 [1] |
 | 2-{4-[4-(2-Pyrrolidin-1-yl-ethoxy)-phenoxy]-phenyl}-oxazole | IC50 | 43.0 [1], 55.0 [2] |
 | 5-Benzyloxy-DL-tryptophan | IC50 | 17300.0 [1], 231000.0 [2] |
 | 1-[2-(4-Phenylphenoxy)ethyl]pyrrolidine | IC50 | 200.0 [1], 790.0 [2] |
 | 1-[2-(4-Benzylphenoxy)ethyl]pyrrolidine | IC50 | 26.0 [1], 120.0 [2] |
 | 4-(4-Benzylphenyl)-1,3-thiazol-2-amine | IC50 | 400.0 [1], 7610.0 [2], 12400.0 [3] |
 | 4-(4-Benzylphenyl)-1,3-thiazol-2-amine | Ki | 360.0 [1] |
 | 1-[2-(4-Phenoxyphenoxy)ethyl]pyrrolidine | IC50 | 30.0 [1], 79.0 [2], 780.0 [3] |
 | 2-(4-Phenoxyphenoxy)ethanamine | IC50 | 35.0 [1], 228.0 [2] |
 | 4-((4-(Methyl(2-oxo-2-(4-phenoxyphenylamino)ethyl)amino)piperidin-1-yl)methyl)benzoic acid | IC50 | 60.0 [1], 270.0 [2] |
 | 1-(4-Thiophen-2-ylphenyl)methanamine | IC50 | 98000.0 [1], 106000.0 [2] |
 | (4-Fluorophenyl)(pyridin-4-yl)methanone | IC50 | 3673000.0 [1], 5308000.0 [2], 5380000.0 [3] |
 | 3-[[3-(4-Benzylphenoxy)propyl]amino]propionic acid | IC50 | 140.0 [1], 280.0 [2] |
 | 2-(4-Benzylphenoxy)ethanamine | IC50 | 9.0 [1], 280.0 [2] |
 | 1-[2-(4-Phenylmethanesulfonyl-phenoxy)-ethyl]-pyrrolidine | IC50 | 4000.0 [1], 7700.0 [2] |
 | 1-[2-(4-Benzylphenoxy)ethyl]piperidine | IC50 | 55.0 [1], 170.0 [2] |
 | 4-[4-(2-Pyrrolidin-1-yl-ethoxy)-benzyl]-thiazole | IC50 | 190.0 [1], 240.0 [2] |
 | 1-[2-(4-Benzyl-2-chloro-phenoxy)-ethyl]-pyrrolidine | IC50 | 1200.0 [1], 1230.0 [2], 2000.0 [3] |
 | 3-[4-(4-Benzyl-phenoxy)-butylamino]-propionic acid | IC50 | 18.0 [1], 490.0 [2] |
 | 3-{Methyl-[3-(4-pyridin-3-ylmethyl-phenoxy)-propyl]-amino}-propionic acid methyl ester | IC50 | 300.0 [1], 820.0 [2] |
 | {[4-(4-Benzyl-phenoxy)-butyl]-methyl-amino}-acetic acid | IC50 | 110.0 [1], 450.0 [2] |
 | 3-[2-(4-Benzyl-phenoxy)-ethylamino]-propionic acid methyl ester | IC50 | 220.0 [1], 590.0 [2] |
 | 1-(1-{2-[4-(1,3-Benzothiazol-2-yloxy)phenoxy]ethyl}piperidin-4-yl)pyrrolidin-2-one | IC50 | 9.7 [1], 16.0 [2], 365.0 [3] |
 | N-[4-(Benzyloxy)phenyl]glycinamide | IC50 | 135.0 [1], 280.0 [2], 300.0 [3] |
 | (R)-4-(2-((4-(4-Chlorophenoxy)phenoxy)methyl)pyrrolidin-1-yl)butanoic acid | IC50 | 33.0 [1], 68.5 [2], 70.8 [3] |
 | 2-(Methyl-{3-[methyl-(4-sulfamoyl-benzyl)-amino]-propyl}-amino)-N-(4-phenoxy-phenyl)-acetamide | IC50 | 33.0 [1], 1000.0 [2] |
 | 4-((Methyl(3-(methyl(2-oxo-2-(4-phenoxyphenylamino)ethyl)amino)propyl)amino)methyl)benzoic acid | IC50 | 6.0 [1], 120.0 [2] |
 | 4-[[[2,2-Dimethyl-3-[methyl-[2-oxo-2-(4-phenoxyanilino)ethyl]amino]propyl]-methylamino]methyl]benzoic acid | IC50 | 7.0 [1], 70.0 [2] |
 | 4-((Methyl(2-(methyl(2-oxo-2-(4-phenoxyphenylamino)ethyl)amino)ethyl)amino)methyl)benzoic acid | IC50 | 15.0 [1], 140.0 [2] |
 | 4-[[Methyl-[3-[methyl-[2-oxo-2-(4-phenoxyanilino)ethyl]amino]propyl]amino]methyl]cyclohexane-1-carboxylic acid | IC50 | 25.0 [1], 430.0 [2] |
 | 3-{Methyl-[3-(4-thiophen-3-ylmethyl-phenoxy)-propyl]-amino}-propionic acid | IC50 | 2.0 [1], 190.0 [2] |
 | 3-[Methyl[3-[4-(biphenyl-4-yloxy)phenoxy]propyl]amino]propanoic acid | IC50 | 0.5 [1], 190.0 [2] |
 | 2-[4-[4-(2-Pyrrolidin-1-ylethoxy)phenoxy]phenyl]-4,5-dihydro-1,3-oxazole | IC50 | 550.0 [1], 590.0 [2] |
 | Sodium valproate | IC50 | 10000.0 [1] |
 | Resveratrol | IC50 | 212000.0 [1], 366000.0 [2] |
 | Trichostatin A | IC50 | 10000.0 [1] |
 | Vorinostat | IC50 | 1670.0 [1], 7650.0 [2] |
 | Nimesulide | IC50 | 100000.0 [1] |
 | 4-(Dimethylamino)-n-[7-(hydroxyamino)-7-oxoheptyl]benzamide | IC50 | 300.0 [1], 680.0 [2] |
 | Zileuton | IC50 | 850.0 [1], 100000.0 [2] |
 | Entinostat | IC50 | 10000.0 [1] |
 | Panobinostat | IC50 | 10000.0 [1] |
 | [6]-Gingerol | IC50 | 56120.0 [1], 58290.0 [2] |
 | 5-Hydroxyindole | IC50 | 1000000.0 [1], 2000000.0 [2] |
 | Shogaol | IC50 | 12540.0 [1], 24610.0 [2] |
 | Belinostat | IC50 | 10000.0 [1] |
 | Mocetinostat | IC50 | 10000.0 [1] |
 | Tubacin | IC50 | 10000.0 [1] |
 | Scriptaid | IC50 | 4400.0 [1], 10000.0 [2] |
 | Tesmilifene | IC50 | 160.0 [1], 400.0 [2] |
 | Ricolinostat | IC50 | 10000.0 [1] |
 | Abexinostat | IC50 | 10000.0 [1] |
 | Quisinostat | IC50 | 10000.0 [1] |
 | Dihydroresveratrol | IC50 | 145000.0 [1], 247000.0 [2] |
 | Pracinostat | IC50 | 10000.0 [1] |
 | Givinostat | IC50 | 10000.0 [1] |
 | Cudc-101 | IC50 | 10000.0 [1] |
 | 5-Fluoroindole | IC50 | 1000000.0 [1], 2000000.0 [2] |
 | Resminostat | IC50 | 10000.0 [1] |
 | 5-Chloroindole | IC50 | 1000000.0 [1], 1510000.0 [2] |
 | 2-Amino-3-benzyloxypyridine | IC50 | 308000.0 [1], 619000.0 [2] |
 | N-(Pyridin-3-ylmethyl)aniline | IC50 | 1321000.0 [1], 1667000.0 [2] |
 | N-(6-(2-Aminophenylamino)-6-oxohexyl)-4-methylbenzamide | IC50 | 10000.0 [1] |
 | 2-(1-Benzyl-5-methoxy-2-methyl-1h-indol-3-yl)acetamide | IC50 | 100000.0 [1] |
 | 7-Benzyloxytryptamine | IC50 | 12500.0 [1], 217000.0 [2] |
 | 4-(2-Amino-1,3-thiazol-4-yl)phenol | IC50 | 1000000.0 [1], 1443000.0 [2] |
 | 5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)dodecan-3-one | IC50 | 100000.0 [1] |
 | 3-Decanone, 1-(4-hydroxy-3-methoxyphenyl)-5-methoxy- | IC50 | 100000.0 [1] |
 | (2S,3S)-3-Amino-2-hydroxy-4-phenylbutanoic acid | IC50 | 1000000.0 [1] |
 | (S)-4-(2-((4-(4-Chlorophenoxy)phenoxy)methyl)pyrrolidin-1-yl)butanoic acid | IC50 | 37.0 [1], 47.0 [2] |
 | 5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)tetradecan-3-one | IC50 | 15240.0 [1], 21590.0 [2] |
 | (S)-4-Methyl-2-[[(2S,3S)-2-hydroxy-3-amino-4-phenylbutanoyl]amino]pentanoic acid | IC50 | 20000.0 [1] |
 | 1-[2-(4-Benzyl-phenoxy)-ethyl]-azepane | IC50 | 37.0 [1], 120.0 [2] |
 | 4-Benzylphenoxy-N-ethylmorpholine | IC50 | 230.0 [1], 1320.0 [2] |
 | 3-[[(2S,3R)-2-Hydroxy-3-amino-4-phenylbutanoyl]amino]propanoic acid | IC50 | 100000.0 [1] |
 | 5-[2-(4-Benzylphenoxy)ethyl]-5H-imidazo[4,5-c]pyridine | IC50 | 11.0 [1] |
 | N-{1-[2-(4-Benzyl-phenoxy)-ethyl]-piperidin-4-yl}-acetamide | IC50 | 50.0 [1] |
 | 1-[2-(4-Benzylphenoxy)ethyl]pyrrolidine-3-ol | IC50 | 30.0 [1] |
 | 1-[1-[2-(4-Benzylphenoxy)ethyl]-4-piperidinyl]urea | IC50 | 87.0 [1] |
 | 5-Benzyloxytryptamine hydrochloride | IC50 | 13000.0 [1], 100000.0 [2] |
 | 5-Hydroxy-1-(4-hydroxy-3-methoxyphenyl)octan-3-one | IC50 | 100000.0 [1] |
 | 1-(3,4-Dimethoxyphenyl)-5-hydroxydecan-3-one | IC50 | 100000.0 [1] |
 | 3,3-Difluoro-4-oxo-6-phenyl-5-hexenoic acid ethyl ester | IC50 | 5000000.0 [1] |
 | Shogaol acetate | IC50 | 9310.0 [1], 29470.0 [2] |
 | 3-(3-Amino-2-hydroxy-4-phenyl-butyrylamino)-propionic acid | IC50 | 80000.0 [1] |
 | 1-{2-[4-(4-Methoxy-benzyl)-phenoxy]-ethyl}-pyrrolidine | IC50 | 70.0 [1], 890.0 [2] |
 | 1-[3-(4-Benzyl-phenyl)-allyl]-pyrrolidine | IC50 | 260.0 [1], 320.0 [2] |
 | 1-[2-(4-Benzyl-benzenesulfinyl)-ethyl]-pyrrolidine | IC50 | 9700.0 [1], 14000.0 [2] |
 | 1-[2-(4-Benzyl-phenoxy)-propyl]-pyrrolidine | IC50 | 700.0 [1], 790.0 [2] |
 | 1-[2-[4-(alpha-Hydroxybenzyl)phenoxy]ethyl]pyrrolidine | IC50 | 1800.0 [1], 4600.0 [2] |
 | 1-{2-[4-(3-Chloro-benzyl)-phenoxy]-ethyl}-pyrrolidine | IC50 | 80.0 [1], 160.0 [2] |
 | 1-[2-(4-Phenethyl-phenoxy)-ethyl]-pyrrolidine | IC50 | 220.0 [1] |
 | 1-[3-(4-Benzyl-phenyl)-propyl]-pyrrolidine | IC50 | 670.0 [1], 1300.0 [2] |